Pharmaceuticals, Biotechnology and Life Sciences
LA JOLLA, Calif., June 29, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
Montrouge, France, June 28, 2022 DBV Technologies to Participate in Upcoming EAACI 2022 Congress DBV Technologies (Euronext: DBV – ISIN:…
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…
LungFit® PH received FDA approval for the treatment of term and near-term neonates with hypoxic respiratory failure on June 28,…
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) — Cellectis S.A. held its Annual Shareholders’ General Meeting (Euronext Growth: ALCLS –…
– IVX-121 demonstrated robust immunologic response to RSV, with comparable Geometric Mean Titer (GMT) levels achieved at Day 28 in…
EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) — Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement…
SANTA MONICA, Calif., June 28, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company…
2021 report demonstrates focus on ESG initiatives supporting health equity, social justice, and sustainability SALT LAKE CITY, June 28, 2022…
LungFit PH is the first FDA-approved product that generates on-demand nitric oxide from ambient air for the treatment of term…